Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine/threonine-protein kinase PLK1 (PLK1) is a key regulatory enzyme that plays essential roles in cell cycle progression, particularly during mitosis. It is a master regulator of multiple processes during cell division, including centrosome maturation, spindle assembly, kinetochore function, chromosome segregation, and cytokinesis. PLK1 is highly expressed in many cancers, making it an attractive target for anticancer therapy. Several inhibitors are under clinical investigation.
PLK1 inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine/threonine-protein kinase PLK1 (PLK1).